Matthew K. Fust, Director: Ultragenyx Pharmaceutical RARE Sell · Filed 24/03/11

Trade details

Type: Insider sale
Amount: $381,600
Shares · price: 7,500 sh · $50.88 a share
Held after: 14,860 sh
Stock: Ultragenyx Pharmaceutical RARE
Person: Matthew K. FustDirector
Trade date: 24/03/07
Filed: 24/03/11
Days to filing: 4 days

Sold 33.5% of holdings

Share of holding sold: 33.5%

Ultragenyx Pharmaceutical trades, last 26 weeks

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 24/02/06~24/04/06

Matthew K. Fust's recent trades

Matthew K. FustDirector
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$716K
16,000 sh
$716K
Filed 25/09/30
Traded 25/09/26
Matthew K. FustDirector
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$239.3K
14,049 sh
$239.3K
Filed 24/10/18
Traded 24/10/18
Matthew K. FustDirector
Sell10b5-1 planNeumora Therapeutics
Sell10b5-1 plan
Neumora Therapeutics
NMRA
$131.6K
7,739 sh
$131.6K
Filed 24/10/18
Traded 24/10/17
Matthew K. FustDirector
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$796.3K
17,500 sh
$796.3K
Filed 24/03/22
Traded 24/03/20
Matthew K. FustDirector
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$762.7K
17,500 sh
$762.7K
Filed 24/03/22
Traded 24/03/20

Matthew K. Fust, Director — sold $381.6K of Ultragenyx Pharmaceutical RARE · 33.5% of holdings · 10b5-1 plan | Whalegun